Church W R, Messier T, Howard P R, Amiral J, Meyer D, Mann K G
Department of Biochemistry, University of Vermont, Burlington 05405.
J Biol Chem. 1988 May 5;263(13):6259-67.
A murine monoclonal antibody (designated H-11) produced by injecting mice with purified human protein C was found to bind several human vitamin K-dependent proteins. Using a solid-phase competitive radioimmunoassay with antibody immobilized onto microtiter plates, binding of 125I-labeled protein C to the antibody was inhibited by increasing amounts of protein C, prothrombin, and Factors X and VII over a concentration range of 1 X 10(-8) to 1 X 10(-6) M. Other vitamin K-dependent proteins including Factor IX and protein S did not inhibit or inhibited only at the highest concentration binding of radiolabeled protein C to the immobilized antibody. Chemical treatment of prothrombin with a variety of agents including denaturation by sodium dodecyl sulfate, reduction with mercaptoethanol followed by carboxymethylation with iodoacetic acid, citraconylation of lysine residues, removal of metal ion with EDTA, or heat decarboxylation did not destroy the antigenic site recognized by the antibody as measured by immunoblotting of prothrombin or prothrombin derivative immobilized onto nitrocellulose. Immunoblotting of purified vitamin K-dependent polypeptides with the monoclonal antibody following sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrophoretic transfer to nitrocellulose indicated that the antigenic site was found on the light chains of protein C and Factor X. Chymotrypsin digestion of prothrombin and isolation on QAE-Sephadex of the peptide representing amino-terminal residues 1-44 of prothrombin further localized the antigenic site recognized by the monoclonal antibody to the highly conserved gamma-carboxyglutamic acid-containing domain. The exact location of the antigenic determinant for antibody H-11 was established using synthetic peptides. Antibody H-11 bound specifically to synthetic peptides corresponding to residues 1-12 of Factor VII and 1-22 of protein C. Comparison of protein sequences of bovine and human vitamin K-dependent proteins suggests that the sequence Phe-Leu-Glu-Glu-Xaa-Arg/Lys is required for antibody binding. The glutamic acid residues in this peptide segment are the first 2 gamma-carboxyglutamic acid residues near the amino-terminal end in the native proteins. Increasing concentrations of Ca2+, Mg2+, or Mn2+ partially inhibited binding of 125I-protein C to the antibody in a solid-phase assay system with half-maximal binding observed at divalent metal ion concentrations of 2, 4, and 0.6 mM, respectively.(ABSTRACT TRUNCATED AT 400 WORDS)
通过给小鼠注射纯化的人蛋白C产生的一种鼠单克隆抗体(命名为H - 11),被发现能结合几种人维生素K依赖性蛋白。使用固定在微量滴定板上的抗体进行固相竞争性放射免疫测定,在1×10⁻⁸至1×10⁻⁶M的浓度范围内,随着蛋白C、凝血酶原、因子X和因子VII量的增加,¹²⁵I标记的蛋白C与抗体的结合受到抑制。其他维生素K依赖性蛋白,包括因子IX和蛋白S,在最高浓度时才抑制或不抑制放射性标记的蛋白C与固定化抗体的结合。用多种试剂对凝血酶原进行化学处理,包括用十二烷基硫酸钠变性、用巯基乙醇还原后用碘乙酸进行羧甲基化、赖氨酸残基的柠康酰化、用乙二胺四乙酸去除金属离子或加热脱羧,通过对固定在硝酸纤维素上的凝血酶原或凝血酶原衍生物进行免疫印迹测定,发现这些处理都没有破坏抗体识别的抗原位点。在十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳和电泳转移到硝酸纤维素上之后,用单克隆抗体对纯化的维生素K依赖性多肽进行免疫印迹表明,抗原位点存在于蛋白C和因子X的轻链上。凝血酶原经胰凝乳蛋白酶消化,并在QAE - 葡聚糖凝胶上分离代表凝血酶原氨基末端残基1 - 44的肽段,进一步将单克隆抗体识别的抗原位点定位到高度保守的含γ - 羧基谷氨酸的结构域。使用合成肽确定了抗体H - 11抗原决定簇的确切位置。抗体H - 11特异性结合对应于因子VII残基1 - 12和蛋白C残基1 - 22的合成肽。牛和人维生素K依赖性蛋白的序列比较表明,抗体结合需要序列Phe - Leu - Glu - Glu - Xaa - Arg/Lys。该肽段中的谷氨酸残基是天然蛋白中氨基末端附近的前两个γ - 羧基谷氨酸残基。在固相测定系统中,Ca²⁺、Mg²⁺或Mn²⁺浓度增加会部分抑制¹²⁵I - 蛋白C与抗体的结合,在二价金属离子浓度分别为2、4和0.6 mM时观察到半最大结合。(摘要截短至400字)